PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 128 filers reported holding PTC THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $367,000 | +19.5% | 8,165 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $307,000 | +30.1% | 8,165 | +18.9% | 0.00% | 0.0% |
Q4 2018 | $236,000 | -26.9% | 6,866 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $323,000 | -1.8% | 6,866 | -77.2% | 0.00% | 0.0% |
Q4 2016 | $329,000 | -20.0% | 30,110 | +2.6% | 0.00% | 0.0% |
Q3 2016 | $411,000 | +118.6% | 29,360 | +9.7% | 0.00% | 0.0% |
Q2 2016 | $188,000 | +6.2% | 26,760 | -2.7% | 0.00% | 0.0% |
Q1 2016 | $177,000 | -85.1% | 27,510 | -24.9% | 0.00% | -75.0% |
Q4 2015 | $1,187,000 | +40.6% | 36,640 | +15.9% | 0.00% | +33.3% |
Q3 2015 | $844,000 | -40.9% | 31,610 | +6.5% | 0.00% | -40.0% |
Q2 2015 | $1,429,000 | -15.4% | 29,690 | +7.0% | 0.01% | -16.7% |
Q1 2015 | $1,689,000 | -63.7% | 27,750 | -69.1% | 0.01% | -62.5% |
Q4 2014 | $4,647,000 | +14.9% | 89,767 | -2.4% | 0.02% | +6.7% |
Q3 2014 | $4,046,000 | +68.4% | 91,937 | 0.0% | 0.02% | +66.7% |
Q2 2014 | $2,403,000 | 0.0% | 91,937 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $2,403,000 | – | 91,937 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |